An Evaluation of the Safety, Efficacy, and Pharmacoeconomics of Two Valganciclovir Prophylaxis Regimens Following Renal Transplantation

被引:0
|
作者
Chen, J. [1 ]
Hoffman, R. [2 ]
Thomas, M. [2 ]
Gervasio, J. [2 ]
机构
[1] Univ Hosp, IU Hlth, Indianapolis, IN USA
[2] Butler Univ, Indianapolis, IN 46208 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
C276
引用
下载
收藏
页码:689 / 689
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of valganciclovir in prophylaxis of cytomegalovirus disease in renal transplant recipients.
    Gabardi, S
    Powelson, J
    Baroletti, SA
    Cina, JL
    Goggins, WC
    PHARMACOTHERAPY, 2003, 23 (03): : 412 - 413
  • [2] Low Dose Valganciclovir Prophylaxis Following Renal Transplantation With Steroid Free Immunosuppression
    Chen, J.
    Shah, A.
    Sauer, M.
    Taber, T.
    Sharfuddin, A.
    Yaqub, M.
    Mishler, D.
    Powelson, J.
    Goggins, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [3] Efficacy and Safety According to Dose of Valganciclovir for Cytomegalovirus Prophylaxis in Transplantation Network Meta Analysis
    Hwang, S.
    Park, W.
    Kim, K.
    Song, J.
    Lee, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 804 - 804
  • [4] Efficacy and safety of low-dose valganciclovir prophylaxis among renal transplant recipients
    Sayilar, Emel Isiktas
    Ergun, Ihsan
    CUKUROVA MEDICAL JOURNAL, 2020, 45 (01): : 347 - 351
  • [5] Safety and Efficacy of Renal Transplantation Following Lung Transplantation
    McMenomy, Ted
    Holland, Mehgan
    Meyer, Keith
    CHEST, 2014, 145 (03)
  • [6] Antimicrobial prophylaxis regimens following transplantation
    Subramanian, Aruna K.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2011, 24 (04) : 344 - 349
  • [7] Efficacy and Safety of Prolonged Valganciclovir Prophylaxis in Children after Living Donor Liver Transplantation.
    Ueno, T.
    Ibuka, S.
    Masahata, K.
    Nomura, M.
    Nara, K.
    Uehara, S.
    Soh, H.
    Oue, T.
    Kondou, H.
    Usui, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 249 - 249
  • [8] Efficacy and safety of oral valganciclovir (VGC) for CMV prophylaxis in pediatric orthotopic liver transplantation (POLT).
    Chang, IF
    Barshes, NR
    Prendergast, DR
    Carter, BA
    Bristow, LJ
    Karpen, SJ
    Scott, JD
    O'Mahony, CA
    Goss, JA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 559 - 560
  • [9] Valganciclovir Prophylaxis is Not Associated with Polyomavirus Viremia after Renal Transplantation
    Conti, D.
    Schuster, D.
    Garner, M.
    Maciera, E.
    Patel, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 821 - 821
  • [10] Evaluation of the Safety and Efficacy of Valganciclovir to Prevent Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients Utilizing Two Dosing Regimens
    Le, K.
    Patel, A.
    Jasiak-Panek, N. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 379 - 379